Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Medtronic
Moodys
AstraZeneca
Colorcon

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Shire LLC, Supernus Pharmaceuticals, Incl v. IMPAX Laboratories, Inc. (N.D. Cal. 2010)

See Plans and Pricing

« Back to Dashboard

Shire LLC, Supernus Pharmaceuticals, Incl v. IMPAX Laboratories, Inc. (N.D. Cal. 2010)

Docket   Start Trial Date Filed 2010-12-02
Court District Court, N.D. California Date Terminated 2013-06-19
Cause 35:145 Patent Infringement Assigned To Richard G. Seeborg
Jury Demand None Referred To Magistrate Judge Maria-Elena J
Parties ANDA, INC; IMPAX LABORATORIES, INC.; M.D. PASKO RAKIC; M.D. ROBERT D. HUNT; PH.D AMY F.T, ARNSTEN; SHIRE LLC, SUPERNUS PHARMACEUTICALS, INC; WATSON LABORATORIES, INC.-FLORIDA; WATSON PHARMA, INC.; WATSON PHARMACEUTICALS, INC.
Patents 5,378,474; 5,854,290; 6,287,599; 6,303,607; 6,811,794
Attorneys Benjamin A. Katzenellenbogen; Colin Barry Heideman; Erika V. Selli; Heather Morehouse Ettinger; Jeffrey James Toney; John Lincoln North; Jonathan David Olinger; Joseph R. Robinson; Joseph V. Saphia; Laura Fahey Fritts; Matthew Daniel Murphey; Norman E.B. Minnear; Sarika Singh; Scott Robert Raber; Sheila Neha Swaroop; William G. Gaede , III; William Rolland Zimmerman
Firms Kasowitz Benson Torres and Friedman; Kasowitz, Benson, Torres & Friedman LLP; Knobbe Martens Olson & Bear LLP; Knobbe Martens Olson and Bear; McDermott Will and Emery LLP; Troutman Sanders LLP; Troutman Sanders LLP, the Chrysler Building; Wiggin and Dana LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Shire LLC, Supernus Pharmaceuticals, Incl v. IMPAX Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Shire LLC, Supernus Pharmaceuticals, Incl v. IMPAX Laboratories, Inc. (N.D. Cal. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-09-12 109 infringed one or more claims of United States Patents Nos. 5,854,290 (the “’290 … 18 patent’); 6,287,599 (the “’599 patent”); and 6,811,794 (the “’794 patent”) by filing a … 3 §§ 2201 & 2202, and the Patent Laws of the United States, 35 U.S.C. § 100 et seq… 10 Patent Laws of the United States, 35 U.S.C. § 100 et seq… 19 claims of the ‘290, ‘599, and ‘794 patents. External link to document
2011-09-12 110 declaratory judgment that U.S. Patent Nos. 5,854,290 (“the ‘290 patent”), …action for declaratory judgment that U.S. Patent Nos. 5,854,290 (“the … 7 ‘290 patent”), 6,287,599 (“the ‘599 patent”), and 6,811,794 (“the ‘794 patent”) are invalid … 6 14. The ‘290 patent, ‘599 patent, and ‘794 patent are listed in the FDA’s Orange Book…enforceable claim of the ‘290 patent, the ‘599 patent, or the ‘794 patent. External link to document
2011-09-26 113 Defendants. 16 The first patent, U.S. Patent No. 5,854,290, generally claims a method of treating… The final two patents, U.S. Patent Nos. 6,287,599 and 6,811,794 (the ‘794 patent), generally 20 …necessary to make infringement contentions under Patent Local Rule 3-1. 3 2. Watson Defendants… Infringement Contentions Under Patent Local Rule 3-1. 5 Watson Defendants … needed to serve infringement contentions under Patent Local Rule 3-1. Case law supports 8 Watson External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Harvard Business School
Baxter
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.